Although targeted plasma biomarker analysis implicates inflammatory changes in RHI (e.g., elevated plasma IL-6) compared to both healthy controls and individuals with Alzheimer’s disease (AD) [19], unbiased plasma proteomics has not been applied to clinically symptomatic, living individuals with prior RHI. The gene discussed is IL6; the disease is Alzheimer disease.